MarginsXMarginsX
Home › Markets › PRNAF

Alterity Therapeutics LTD (PRNAF)

PRNAF is quoted over the counter, not listed on an exchange. Alterity Therapeutics LTD files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 11, 2026
$0.2000
No trades since Nov 11, 2026; later closes repeat the last quote
1-year return
+2757.1%
Market cap
The company also trades on Nasdaq as ATHE; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to June 30, 2026 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerPRNAF, quoted over the counter
SEC CIK0001131343
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressMelbourne
Incorporated inAustralia

Warning signs

Cash runway
19.9 months
37.3M AUD cash at June 30, 2026
Share count, 1 year
See the dilution note
Going-concern doubt
No
20-F filed August 28, 2026
Insider net buying, 12 months
$24K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-08-28
Cash and burn37.3M AUD cash; operating cash flow -5.6M AUD a quarter.Report 2026-06-30
Shares outstanding18,125,739 (2026-06-30); 760,614,224 a year earlier; 203,324,802 three years earlier. share count fell by more than half since 2025-06-30 with no split on record, which usually means a reverse split; 1y dilution not computed; share count fell by more than half since 2023-06-30 with no split on record, which usually means a reverse split; 3y dilution not computed.Cover page 2026-06-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers, Melbourne, AustraliaPCAOB Form AP 2026-09-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $24K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-06-30
Not filed-23.4M AUD-22.5M AUD37.3M AUDNo debt tagsNeeds four quarters20-F 2026-08-28
FY 2025
2025-06-30
Not filed-12.1M AUD-11.5M AUD33.2M AUDNo debt tagsNeeds four quarters20-F 2025-08-29
FY 2024
2024-06-30
Not filed-19.1M AUD-12.6M AUD12.6M AUDNo debt tagsNeeds four quarters20-F 2025-08-29
FY 2023
2023-06-30
Not filed13.8M AUD-20.0M AUD15.8M AUDNo debt tagsNeeds four quarters20-F 2023-08-31
FY 2022
2022-06-30
Not filed12.8M AUD-12.3M AUD34.8M AUDNo debt tagsNeeds four quarters20-F 2023-08-31
FY 2021
2021-06-30
Not filed15.3M AUD-17.3M AUD28.1M AUDNo debt tagsNeeds four quarters20-F 2023-08-31
FY 2020
2020-06-30
Not filed13.5M AUD-9.4M AUD9.2M AUDNo debt tagsNeeds four quarters20-F 2022-08-31
FY 2019
2019-06-30
Not filed12.3M AUD-14.0M AUD14.4M AUDNo debt tagsNeeds four quarters20-F 2021-09-02

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in AUD.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52024-02-15
Latest annual report20-F2026-08-28
Latest quarterly / interim6-K2026-11-12

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier